References
- Wilking N, Jönsson B. Cancer and economics: with a special focus on cancer drugs. Oncol News 2011;6:17–9.
- http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm278383.htm.
- EMA, Committee for Medicinal Products for Human Use (CHMP). Assessment report Zytiga (abiraterone). 21 July 2011. Procedure No.: EMEA/H/C/002321.
- EMA, Committee for Medicinal Products for Human Use (CHMP). Assessment report Yervoy (ipilimumab). 19 May 2011. Procedure No.: EMEA/H/C/002213.
- EMA, CHMP, Guideline on the Evaluation of Anticancer Medicinal Products in Man. London: EMA. December 2005.